Non-myeloablative allogeneic stem cell transplantation in multiple myeloma after relapse: low transplant-related morbidity and mortality

Ähnliche Einträge

• Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine
  von: Görner, Martin, et al.
  Veröffentlicht: (2002)
• Molecular monitoring of tumour load kinetics predicts disease progression after non-myeloablative allogeneic stem cell transplantation in multiple myeloma
  von: Raab, Marc-Steffen, et al.
  Veröffentlicht: (2005)
• Allogeneic immunotherapy for relapsed multiple myeloma: role of matched unrelated donors
  von: Görner, Martin, et al.
  Veröffentlicht: (2002)
• Thalidomide plus CED chemotherapy as regimen for remission induction in poor-prognosis multiple myeloma prior to autologous or allogeneic haematopoietic stem cell transplantation
  von: Möhler, Thomas, et al.
  Veröffentlicht: (2002)
• Pre-transplant serum leptin levels and relapse of acute myeloid leukemia after allogeneic transplantation
  von: Schwarzbich, Mark-Alexander, et al.
  Veröffentlicht: (2022)